News >

Sequencing Challenges Emerge in Myeloma as Options Expand

Kristi Rosa
Published: Monday, Apr 22, 2019

Omar Nadeem, MD

Omar Nadeem, MD

As more novel agents are added to the treatment paradigm for relapsed/refractory multiple myeloma, Omar Nadeem, MD, stressed that the big challenge lies in determining how best to sequence these therapies.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication
x